Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012;25(1):21-26.

Management of cutaneous disorders related to inflammatory bowel disease

Affiliations
Review

Management of cutaneous disorders related to inflammatory bowel disease

Zaira Pellicer et al. Ann Gastroenterol. 2012.

Abstract

Almost one-third of patients with inflammatory bowel disease (IBD) develop skin lesions. Cutaneous disorders associated with IBD may be divided into 5 groups based on the nature of the association: specific manifestations (orofacial and metastatic IBD), reactive disorders (erythema nodosum, pyoderma gangrenosum, pyodermatitis-pyostomatitis vegetans, Sweet's syndrome and cutaneous polyarteritis nodosa), miscellaneous (epidermolysis bullosa acquisita, bullous pemphigoid, linear IgA bullous disease, squamous cell carcinoma-Bowen's disease, hidradenitis suppurativa, secondary amyloidosis and psoriasis), manifestations secondary to malnutrition and malabsorption (zinc, vitamins and iron deficiency), and manifestations secondary to drug therapy (salicylates, immunosupressors, biological agents, antibiotics and steroids). Treatment should be individualized and directed to treating the underlying IBD as well as the specific dermatologic condition. The aim of this review includes the description of clinical manifestations, course, work-up and, most importantly, management of these disorders, providing an assessment of the literature on the topic.

Keywords: Inflammatory bowel disease; skin disorders; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

Figures

Figure 1
Figure 1
Metastatic Crohn’s disease. Ulcerative and crusting lesion
Figure 2
Figure 2
Erythema nodosum. Multiple red, warm, and tender nodules, classically located on pretibial surface of lower extremity
Figure 3
Figure 3
Pyoderma gangrenosum. Painful and irregularly shaped ulcers with violaceous edges
Figure 4
Figure 4
Sweet’s syndrome. Painful, red, tender edematous papules with pseudovesiculation
Figure 5
Figure 5
Hidradenitis suppurativa. Subcutaneous nodules, sinus tracts, fistulae formation and dermal scarring

References

    1. Kethu SR. Extraintestinal manifestations of inflammatory bowel diseases. J Clin Gastroenterol. 2006;40:467–475. - PubMed
    1. Yüksel I, Basar O, Ataseven H, et al. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:546–550. - PubMed
    1. Georgiou S, Pasmatzi E, Monastirli A, Tsambaos D. Cutaneous manifestations of inflammatory bowel disease. Hosp Chron. 2006;1:158–168.
    1. Gregory B, Ho VC. Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol. 1992;26:371–383. - PubMed
    1. Pittock S, Drumm B, Fleming P, et al. The oral cavity in Crohn's disease. J Pediatr. 2001;138:767–771. - PubMed

LinkOut - more resources